Dr. Otis W. Brawley

Insider Reports History

Location
Buford, GA
Signature
/s/ Shirley Qin, attorney-in-fact for Dr. Otis W. Brawley
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dr. Otis W. Brawley:

Form 4 holding Director

Lyell Immunopharma, Inc.

Security class
Option (right to buy)
Shares / value
130,000
Estimated value
Report date
14 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

PDS Biotechnology Corp

Security class
Employee Stock Option (Right to Buy)
Shares / value
54,876
Estimated value
Report date
12 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

INCYTE CORP

Security class
Non Qualfied Stock Option (right to buy)
Shares / value
9,216
Estimated value
Report date
10 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Dr. Otis W. Brawley

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .